Abstract
Citing growing demand for small-molecule drug development and production, Cambrex says it will spend $50 million to expand its capacity to make active pharmaceutical ingredients in Charles City, Io...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have